https://www.selleckchem.com/pr....oducts/lusutrombopag
In a previous study we reported that anti-Müllerian hormone (AMH), a marker of ovarian reserve, is positively associated with breast cancer risk, consistent with other studies. Assess whether risk factors for breast cancer are correlates of AMH concentration. Cross-sectional. 3831 healthy premenopausal women (aged 21-57, 87% aged 35-49). Ten cohort studies, general population. Adjusting for age and cohort, we observed positive associations of AMH with age at menarche (p0.0001) and parity (p=0.0008), and an inverse association